Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
-4.21%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$16.9B
AUM Growth
-$2.13B
(-11%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
39.23%
Holding
1,372
New
74
Increased
459
Reduced
680
Closed
155
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$126M |
| 2 |
NVIDIA
NVDA
|
+$75.8M |
| 3 |
Synaptics
SYNA
|
+$33.9M |
| 4 |
Microchip Technology
MCHP
|
+$29.7M |
| 5 |
ON Semiconductor
ON
|
+$23.8M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$185M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$169M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$154M |
| 4 |
Apple
AAPL
|
+$136M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$120M |
Sector Composition
| 1 | Technology | 36.16% |
| 2 | Financials | 15.02% |
| 3 | Energy | 6.15% |
| 4 | Healthcare | 5.33% |
| 5 | Consumer Discretionary | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Bank OZK
OZK
$5.88B
| $5.75M | 0.03% |
134,622
+7,982
| +6% | +$341K |
|
352
Enphase Energy
ENPH
$4.92B
| $5.71M | 0.03% |
28,287
-4,911
| -15% | -$991K |
|
353
Insmed
INSM
$30.8B
| $5.68M | 0.03% |
241,500
+41,683
| +21% | +$980K |
|
354
Denali Therapeutics
DNLI
$2.07B
| $5.66M | 0.03% |
175,962
+54,207
| +45% | +$1.74M |
|
|
Y
355
DELISTED
Alleghany Corporation
Y
| $5.66M | 0.03% |
6,682
-330
| -5% | -$280K |
|
|
CCXI
356
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.65M | 0.03% |
225,404
+68,183
| +43% | +$1.71M |
|
357
Opko Health
OPK
$1.11B
| $5.64M | 0.03% |
1,639,109
+752,379
| +85% | +$2.59M |
|
358
Neurocrine Biosciences
NBIX
$14.1B
| $5.62M | 0.03% |
59,896
-6,304
| -10% | -$591K |
|
359
Zentalis Pharmaceuticals
ZNTL
$107M
| $5.59M | 0.03% |
121,170
+55,971
| +86% | +$2.58M |
|
360
Acadia Pharmaceuticals
ACAD
$3.98B
| $5.59M | 0.03% |
230,683
-6,215
| -3% | -$151K |
|
|
HZNP
361
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.58M | 0.03% |
53,064
+650
| +1% | +$68.4K |
|
362
Natera
NTRA
$23.1B
| $5.58M | 0.03% |
137,187
+78,208
| +133% | +$3.18M |
|
363
Amicus Therapeutics
FOLD
$2.46B
| $5.57M | 0.03% |
588,584
+63,739
| +12% | +$604K |
|
364
NetApp
NTAP
$24.8B
| $5.57M | 0.03% |
67,062
-10,273
| -13% | -$853K |
|
365
United Therapeutics
UTHR
$18.3B
| $5.55M | 0.03% |
30,910
+2,946
| +11% | +$529K |
|
|
ISEE
366
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.49M | 0.03% |
326,314
-35,115
| -10% | -$591K |
|
367
Equitable Holdings
EQH
$16.2B
| $5.45M | 0.03% |
176,321
-14,948
| -8% | -$462K |
|
368
Heron Therapeutics
HRTX
$193M
| $5.45M | 0.03% |
952,087
+390,810
| +70% | +$2.24M |
|
369
Keysight
KEYS
$29.3B
| $5.45M | 0.03% |
34,473
-4,466
| -11% | -$706K |
|
|
MRTX
370
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.44M | 0.03% |
66,201
+27,070
| +69% | +$2.23M |
|
371
BioMarin Pharmaceuticals
BMRN
$10.4B
| $5.43M | 0.03% |
70,383
+8,266
| +13% | +$637K |
|
372
Novavax
NVAX
$1.3B
| $5.4M | 0.03% |
73,261
+41,601
| +131% | +$3.06M |
|
373
BioCryst Pharmaceuticals
BCRX
$1.66B
| $5.39M | 0.03% |
331,713
-120,924
| -27% | -$1.97M |
|
374
Ligand Pharmaceuticals
LGND
$3.23B
| $5.38M | 0.03% |
76,655
+17,932
| +31% | +$1.26M |
|
|
BHVN
375
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.34M | 0.03% |
45,001
-7,875
| -15% | -$934K |
|